IMOV
GSK icon

Investment Management of Virginia’s GSK GSK Stock Holding History

Investment Management of Virginia’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,012
Closed -$273K – 173
2022
Q2 		$273K Hold
5,012
– – 0.06% 162
2022
Q1 		$273K Hold
5,012
– – 0.05% 165
2021
Q4 		$276K Buy
5,012
+80
+2% +$4.16K 0.04% 167
2021
Q3 		$236K Buy
4,932
+80
+2% +$4.02K 0.05% 152
2021
Q2 		$242K Sell
4,852
-160
-3% -$7.69K 0.05% 156
2021
Q1 		$223K Buy
5,012
+60
+1% +$2.72K 0.04% 146
2020
Q4 		$228K Buy
4,952
+200
+4% +$9.19K 0.05% 141
2020
Q3 		$224K Sell
4,752
-200
-4% -$10K 0.06% 140
2020
Q2 		$252K Sell
4,952
-448
-8% -$23K 0.06% 134
2020
Q1 		$256K Hold
5,400
– – 0.08% 132
2019
Q4 		$317K Buy
5,400
+1,500
+38% +$83.4K 0.07% 128
2019
Q3 		$208K Buy
+3,900
New +$201K 0.05% 137
2019
Q2 		– Sell
-7,920
Closed -$414K – 152
2019
Q1 		$414K Buy
+7,920
New +$396K 0.05% 150
2017
Q3 		– Sell
-3,880
Closed -$209K – 141
2017
Q2 		$209K Hold
3,880
– – 0.05% 134
2017
Q1 		$204K Buy
+3,880
New +$197K 0.05% 137
2016
Q4 		– Sell
-4,000
Closed -$216K – 145
2016
Q3 		$216K Buy
+4,000
New +$219K 0.05% 140
2015
Q4 		– Sell
-5,242
Closed -$252K – 155
2015
Q3 		$252K Buy
+5,242
New +$273K 0.07% 144
2014
Q3 		– Sell
-18,740
Closed -$1.25M – 150
2014
Q2 		$1.25M Buy
18,740
+280
+2% +$19K 0.2% 113
2014
Q1 		$1.23M Buy
18,460
+14,356
+350% +$971K 0.2% 117
2013
Q4 		$274K Buy
4,104
+120
+3% +$7.78K 0.05% 148
2013
Q3 		$250K Hold
3,984
– – 0.05% 148
2013
Q2 		$249K Buy
+3,984
New +$253K 0.05% 148

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Investment Management of Virginia's GSK Position: Q3 2022 in Review

Investment Management of Virginia sold out of GSK (GSK) in Q3 2022, closing a stake of 5,012 shares — an estimated $273K sold.

Investment Management of Virginia first reported a position in GSK in Q2 2013 and held it in 22 quarters. The position peaked at $1.25M in Q2 2014. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Investment Management of Virginia reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Investment Management of Virginia sold 5,012 GSK shares in Q3 2022, an estimated $273K.
  • Investment Management of Virginia first reported a position in GSK in Q2 2013 and held it in 22 quarters.
  • Investment Management of Virginia's GSK position peaked at $1.25M in Q2 2014.
  • 743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Investment Management of Virginia's 13F filing for Q3 2022, filed 7 Nov 2022.